Search - tctmd.com

Displaying 121 - 140 of 554

Sort: Relevancy | Date

News Daily News

Wearable Devices Are Cost-effective AF Screening Tools

Caitlin E. Cox

August 10, 2022

News Daily News

CMR Could Refine Early Management Decisions in Aortic Regurgitation

L.A. McKeown

July 27, 2022

News Daily News

Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review

Shelley Wood

July 21, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

News Daily News

If You Smoke, Adding in E-Cigs Likely Won’t Cut CV Risks

Caitlin E. Cox

May 13, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Todd Neale

May 02, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

Shelley Wood

April 11, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

News Conference News ACC 2022

Can a Smartphone App Use Voice Patterns to Predict CAD Events?

Caitlin E. Cox

March 24, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Daily News

ACC Releases Guidance on CV Issues With COVID-19

Todd Neale

March 16, 2022

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

Advertisement

Wearable Devices Are Cost-effective AF Screening Tools

CMR Could Refine Early Management Decisions in Aortic Regurgitation

Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

If You Smoke, Adding in E-Cigs Likely Won’t Cut CV Risks

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Can a Smartphone App Use Voice Patterns to Predict CAD Events?

No Stents in STEMI? With Careful Selection, Maybe

ACC Releases Guidance on CV Issues With COVID-19

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content